• 4-Hydroxytamoxifen: Practical Protocol and QC Guide

  2026-09-18

  4-Hydroxytamoxifen (SKU B6167) provides a DMSO-compatible estrogen receptor modulator for controlled in vitro workflows, including breast cancer research, prostate cancer research, apoptosis assays, and cardiac myocyte calcium handling studies. It should not be selected for protocols requiring water- or ethanol-based solubilization, and long-term storage of prepared solutions should be avoided.

• Alfuzosin HCl: Gastroretentive Research Workflows

  2026-09-18

  Build reproducible Alfuzosin HCl assays around receptor pharmacology, smooth-muscle models, and gastroretentive formulation testing. This guide translates a peer-reviewed sponge-delivery study into practical preparation, release-testing, imaging, and troubleshooting workflows for benign prostatic hyperplasia research.

• PQQ–Nrf2–IGF1R Axis in Age-Related Osteoarthritis

  2026-09-17

  This reference study identifies a PQQ–Nrf2–IGF1R pathway that links antioxidant defense to cartilage matrix maintenance in age-related osteoarthritis. Its combination of long-term mouse intervention, inflammatory chondrocyte models, tissue analysis, and loss-of-function experiments provides a mechanistic framework for studying oxidative stress and senescence in joint degeneration.

• Dexamethasone as an Anti-Inflammatory Assay Benchmark

  2026-09-17

  Dexamethasone is a glucocorticoid anti-inflammatory research tool for dissecting NF-κB activity, cell differentiation, autophagy, and neuroinflammation. This article translates a rosemary-root discovery study into a rigorous framework for selecting controls, endpoints, and interpretation strategies.

• Moesin as a Biomarker of Endothelial Injury in Sepsis

  2026-09-16

  The reference study identifies serum moesin (MSN) as a candidate biomarker of endothelial injury and sepsis severity, linking elevated MSN with SOFA scores, procalcitonin, and experimental lung damage. Its combination of patient data, mouse sepsis models, and endothelial-cell mechanistic experiments supports a role for MSN in ROCK1/MLC- and NF-κB-associated barrier dysfunction, while also defining important limits for clinical translation.

• T. pallidum, Mitochondrial ROS, and Hepatocyte Apoptosis

  2026-09-15

  The reference study identifies a mitochondria-centered mechanism by which Treponema pallidum promotes hepatocyte apoptosis: mitochondrial ROS accumulation is associated with cardiolipin peroxidation, mitochondrial dysfunction, and activation of the intrinsic apoptotic cascade. Its integrated measurements provide a useful framework for investigating infection-associated liver injury and for separating mitochondrial permeability changes from downstream cell-death signaling.

• Griseofulvin: A Mechanism-First Assay Guide

  2026-09-15

  Griseofulvin is a microtubule associated inhibitor whose antifungal value depends on separating true mitotic disruption from nonspecific toxicity. This mechanism-first guide connects fungal assays with a validated aneugenic mechanism framework while defining practical limits for cross-domain interpretation.

• Anti-Inflammatory and Anti-Angiogenic Airway Stents

  2026-09-14

  Zhao et al. developed PAGL, an electrospun airway stent combining anlotinib hydrochloride with silver nanoparticles to address infection, inflammation, angiogenesis, and fibroblast activation in tracheal in-stent restenosis. In vitro, rabbit, and RNA-sequencing results support a locally acting, multi-mechanism strategy, while translational limitations remain around long-term safety, dosing, and human validation.

• AAL-993: From VEGFR Biology to Translational Insight

  2026-09-14

  A mechanistic and strategic guide to using AAL-993 as a selective VEGF receptor inhibitor in tumor angiogenesis research, with practical considerations for assay design, model selection, and translational interpretation.

• L1023 Anti-Cancer Compound Library: STING Screening

  2026-09-13

  Use the L1023 Anti-Cancer Compound Library to connect broad oncology chemical space with pathway-focused assays, including kinase, apoptosis, and STING-linked immune readouts. Its pre-dissolved format and 1,164-compound breadth support efficient hit discovery, while orthogonal controls help distinguish pathway modulation from nonspecific cytotoxicity.

• Immunodominant B-Cell Epitopes in P. vivax

  2026-09-12

  This study combines computational immunology, peptide serology, multiplex validation, and sequence conservation analysis to identify B-cell epitopes that can improve surveillance of Plasmodium vivax, including asymptomatic infections. Its strongest candidates offer species-discriminating signals and a practical foundation for next-generation serological tools aimed at hidden transmission reservoirs.

• Reactive Oxygen Species Assay Kit (DHE)

  2026-09-11

  This scenario-based guide explains how Reactive Oxygen Species (ROS) Assay Kit (DHE), SKU K2066, can strengthen intracellular superoxide measurements in viability, cytotoxicity, apoptosis, and mitochondrial studies. It covers controls, live-cell compatibility, protocol optimization, interpretation limits, and practical vendor-selection criteria.

• CD38 CAR-T: From Binding to Cell Death

  2026-09-11

  Structural studies of CD38 CAR binders show why affinity, epitope geometry, and enzymatic inhibition must be optimized together. This thought-leadership guide explains how a 7-AAD membrane-integrity readout can convert those design hypotheses into translationally useful evidence.

• Drosophila Keap1–Lamin Dm0 and Nuclear Architecture

  2026-09-10

  Carlson and colleagues identify a molecular and genetic relationship between Drosophila Keap1 and the B-type lamin Dm0, connecting xenobiotic-response signaling with nuclear lamina organization and heterochromatin distribution. Their combination of localization, chromatin-marker, morphology, and genetic-interaction analyses suggests that dKeap1 can influence developmental phenotypes through higher-order nuclear architecture.

• Capecitabine in Gastric Cancer Assembloids

  2026-09-10

  Capecitabine can help interrogate prodrug activation, stromal drug resistance, and apoptosis in patient-derived gastric cancer assembloids. This article presents a decision-focused framework for separating tumor-selective metabolism from microenvironment-driven response changes.

7810 records 1/521 page Next 12345 下5页 Last page